Boundless Bio, Inc. Common Stock
Stock Forecast, Prediction & Price Target
Boundless Bio, Inc. Common Stock Financial Estimates
Boundless Bio, Inc. Common Stock Revenue Estimates
Boundless Bio, Inc. Common Stock EBITDA Estimates
Boundless Bio, Inc. Common Stock Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $8.4M Low: $8.4M High: $8.4M avg. 0% |
Net Income
% change YoY
| $-25.21M N/A | $-45.90M -82.07% | $-49.43M -7.69% | Avg: $-102.18M Low: $-109.37M High: $-94.74M avg. -106.71% | Avg: $-116.75M Low: $-116.75M High: $-116.75M avg. -14.25% | Avg: $-99.55M Low: $-99.55M High: $-99.55M avg. 14.73% | Avg: $-117.75M Low: $-117.75M High: $-117.75M avg. -18.27% |
EBITDA
% change YoY
| $-24.61M N/A | $-45.52M -84.92% | $-48.47M -6.47% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$1.13 N/A | -$2.06 -82.30% | -$2.22 -7.76% | Avg: -$4.6 Low: -$4.92 High: -$4.26 avg. -106.98% | Avg: -$5.25 Low: -$5.25 High: -$5.25 avg. -14.25% | Avg: -$4.48 Low: -$4.48 High: -$4.48 avg. 14.73% | Avg: -$5.3 Low: -$5.3 High: -$5.3 avg. -18.27% |
Operating Expenses
% change YoY
| $25.30M N/A | $46.46M 83.66% | $54.79M 17.91% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Boundless Bio, Inc. Common Stock stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -31.13% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -109.37M, average is -102.18M and high is -94.74M.
What is Boundless Bio, Inc. Common Stock stock revenue growth forecast?
We have gathered data from N/A analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Boundless Bio, Inc. Common Stock stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -31.19% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$4.92, average is -$4.6 and high is $-4.26.